MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
loss
-$2,252,984
Interest income
$47
Reimbursement grant income
$102,425
Exchange differences on
translation
-$5,315
Net loss
-$2,247,669
Nonoperating income
(expense)
$93,714
Foreign exchange loss
-$8,758
Loss from operations
-$2,341,383
General and
administrative
$1,216,656
Research and development
$1,124,727
Back
Back
Income Statement
source: myfinsight.com
Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. (EDSA)